V
vTv Therapeutics D
D
VTVT
17.700
USD
-1.97
(-10.02%)
مغلق
حجم التداول
317
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
46,324,706
الأخبار المقالات
العنوان: vTv Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.